Feedback / Questions
Gavreto (pralsetinib) - Rigel Pharmaceuticals
Gavreto: Newly added patent in Orange Book
(Orange Book)
-
Sep 9, 2026 -
Expiry on Apr 19, 2043
Patent
•
Lung Cancer • Neuroendocrine Tumor • Non Small Cell Lung Cancer • Oncology • Thoracic Cancer • Thyroid Gland Medullary Carcinoma
https://www.accessdata.fda.gov/scripts/cder/ob/search_patent.cfm?listed=new
Sep 9, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious